Key facts
- Oxford BioMedica has rejected multiple unsolicited offers from EQT.
- The company has left the door open to a potential private equity takeover.
- Any deal would need to be the right fit for Oxford BioMedica.
Oxford BioMedica, a UK-listed company, has stated that it is open to the possibility of a private equity takeover. This comes after the company had already rejected several unsolicited offers from the private equity firm EQT. The company emphasized that any potential deal would need to align with its strategic objectives and be the 'right fit' for its future. The specific terms and valuation of the rejected offers were not disclosed, but the company's stance suggests a willingness to engage if a more suitable proposal is presented.